Cargando…
Gremlin-1 in pregnancy and postpartum: relation to the fatty liver index, markers of bone health, glucose metabolism and gestational diabetes mellitus status
INTRODUCTION: Gremlin-1 is a peptide that functions as an antagonist to bone morphogenic proteins and is overexpressed in obesity and type 2 diabetes mellitus. Gremlin-1 has not yet been investigated in pregnancy, pregnancy-related insulin resistance or gestational diabetes mellitus (GDM). PATIENTS...
Autores principales: | Deischinger, Carola, Bastian, Magdalena, Leitner, Karoline, Bancher-Todesca, Dagmar, Kiss, Herbert, Baumgartner-Parzer, Sabina, Kautzky-Willer, Alexandra, Harreiter, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587257/ https://www.ncbi.nlm.nih.gov/pubmed/37518503 http://dx.doi.org/10.1007/s00592-023-02151-7 |
Ejemplares similares
-
CTRP-1 levels are related to insulin resistance in pregnancy and gestational diabetes mellitus
por: Deischinger, Carola, et al.
Publicado: (2020) -
Secretagogin is Related to Insulin Secretion but Unrelated to Gestational Diabetes Mellitus Status in Pregnancy
por: Deischinger, Carola, et al.
Publicado: (2020) -
Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status
por: Deischinger, Carola, et al.
Publicado: (2021) -
SUN-639 Secretagogin Levels Are Unrelated to Gestational Diabetes Mellitus in a Cohort of Pregnant Women
por: Deischinger, Carola, et al.
Publicado: (2020) -
The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
por: Firneisz, Gábor, et al.
Publicado: (2018)